L'Oréal Dermatological Beauty Pro is a digital community empowering healthcare professionals to improve their daily practice of dermatology through cutting-edge research, science and education on skin and hair care.
Lipikar Baume AP+M the best companion in AD
- 5min
- Oct. 2023
- Supported by
Atopic dermatitis is a chronic skin condition that is characterized by alternating periods of flare-ups and remissions.
Daily use of emollients is the cornerstone in AD management to strengthen the skin barrier and reduce the likelihood of inflammatory flare-ups. However, during flare-ups local immunosuppressants like corticosteroids or immunotherapy may be prescribed. Emollients can be used in adjunct to topical corticosteroids as steroid-sparing agents in the treatment of AD.
Lipikar Baume AP+M has a proven efficacy in adjunctive therapy with topical corticosteroids by lowering their consumption and delaying flare-ups.
Even on the most severe cases when combined with biotherapy.